Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 5Bile Duct Neoplasms 3Jaundice 2Biliary Tract Neoplasms 2Neoplasms 1Hemobilia 1Gallbladder Neoplasms 1Fistula 1Cholestasis 1Cholangiocarcinoma 1Biliary Tract Diseases 1Bile Duct Diseases 1

Interventions

Gemcitabine 35Cisplatin 21Capecitabine 17Oxaliplatin 16Leucovorin 11Fluorouracil 11pembrolizumab 8S 1 (combination) 8Nivolumab 6tremelimumab 5durvalumab 5Bevacizumab 5lenvatinib 4Irinotecan 4trametinib 3titanium silicide 3atezolizumab 3Radiofrequency Ablation 3zanidatamab 2vandetanib 2irinotecan sucrosofate 2derazantinib 2camrelizumab 2binimetinib 2apatinib 2Trastuzumab 2Tegafur 2Radiotherapy 2Panitumumab 2Ipilimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Biliary Tract Neoplasms × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT03504293 2020-12-22

The Diagnostic Value of Combinatory EUS and ERCP in Unclear Lesions

Sahlgrenska University Hospital

Completed
90 enrolled
Gastrointestinal

Biliary Tract Diseases, Biliary Tract Neoplasms, Neoplasms

NCT01758341 2014-01-23

Radiofrequency Ablation for Malignant Biliary Obstruction

Medical University of Vienna

Phase 4 Completed
58 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡